IP Library › Assignment 070266/0875
Patent Assignment
Reel/Frame 070266/0875

Affidavit of Address Change

Recorded: 2025-02-19 Pages: 3
Assignor
MEDERIS DIABETES, LLC
Executed: 2016-12-21
Assignee
MEDERIS DIABETES LLC
7515 GUINEVERE DRIVE, SUGAR LAND, TEXAS, 77479
Covered Properties (17)
Peptide Pharmaceuticals for Insulin Resistance
Application: 14/118,545 →
Publication: US 2014/0349928
Peptide Pharmaceuticals
Application: 14/118,546 →
Publication: US 2015/0031630
Improved Peptide Pharmaceuticals
Application: 14/646,246 →
Publication: US 2015/0307550
Peptide Pharmaceuticals for Insulin Resistance
Application: 14/646,264 →
Publication: US 2015/0290334
Improved Peptide Pharmaceuticals for Insulin Resistance
Patent: 9,856,306 →
Application: 15/314,466 →
Publication: US 2017/0096468
Peptide Pharmaceuticals for Insulin Resistance
Application: 15/820,127 →
Publication: US 2018/0194826
Peptide Pharmaceuticals
Application: 15/913,845 →
Publication: US 2018/0296681
Peptide Pharmaceuticals
Application: 15/986,707 →
Publication: US 2018/0327454
Improved Peptide Pharmaceuticals
Application: 16/579,799 →
Publication: US 2021/0077629
Peptide Pharmaceuticals for Insulin Resistance
Application: 16/747,759 →
Publication: US 2020/0277351
Improved Peptide Pharmaceuticals for Insulin Resistance
Application: 16/826,208 →
Publication: US 2020/0289653
Improved Peptide Pharmaceuticals for Treatment of Nash and Other Disorders
Application: 16/958,597 →
Publication: US 2020/0352900
Peptide Pharmaceuticals
Application: 17/031,583 →
Publication: US 2022/0348611
Peptide Pharmaceuticals for Insulin Resistance
Application: 17/349,195 →
Publication: US 2022/0362345
Peptide Pharmaceuticals for Insulin Resistance
Application: 18/587,927 →
Publication: US 2024/0424062
Peptide Pharmaceuticals for Insulin Resistance
Application: 18/943,440 →
Publication: US 2025/0136656
Peptide Pharmaceuticals for Insulin Resistance
Application: 18/988,066 →
Publication: US 2025/0313604
Related Assignments (24)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2013
From: NESTOR, JOHN J.
To: MEDERIS DIABETES, LLC
Reel/Frame 031639/0525 →
Assignment of Assignor's Interest Nov 20, 2013
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACEUTICALS, INC.
Reel/Frame 031639/0517 →
Assignment of Assignor's Interest Jun 24, 2015
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACEUTICALS, INC.
Reel/Frame 036016/0858 →
Assignment of Assignor's Interest Jun 24, 2015
From: NESTOR, JOHN J.
To: MEDERIS DIABETES, LLC
Reel/Frame 036016/0860 →
Assignment of Assignor's Interest Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044183/0041 →
Assignment of Assignor's Interest Nov 20, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044182/0962 →
Assignment of Assignor's Interest Nov 21, 2017
From: NESTOR, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 044194/0772 →
Assignment of Assignor's Interest May 22, 2018
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACEUTICALS, INC.
Reel/Frame 045876/0901 →
Assignment of Assignor's Interest Jun 1, 2018
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACEUTICALS, INC.
Reel/Frame 045963/0694 →
Assignment of Assignor's Interest Jul 20, 2019
From: SPITFIRE PHARMA INC.
To: MEDERIS DIABETES INC.
Reel/Frame 049809/0931 →
Assignment of Assignor's Interest Jul 20, 2019
From: EUMEDERIS PHARMACEUTICALS INC.
To: MEDERIS DIABETES INC.
Reel/Frame 049809/0925 →
Assignment of Assignor's Interest Jun 26, 2020
From: SPITFIRE PHARMA INC.
To: MEDERIS DIABETES LLC
Reel/Frame 053059/0865 →
Assignment of Assignor's Interest Jul 7, 2020
From: NESTOR, JOHN
To: SPITFIRE PHARMA INC
Reel/Frame 053135/0049 →
Corrective Assignment to Correct the Application Number Previously Recorded at Reel: 053135 Frame: 0049. Assignor(S) Hereby Confirms the Assignment. Dec 9, 2020
From: NESTOR, JOHN J
To: SPITFIRE PHARMA INC
Reel/Frame 054660/0673 →
Assignment of Assignor's Interest Feb 19, 2025
From: EUMEDERIS PHARMACEUTICALS, INC.
To: MEDERIS DIABETES LLC
Reel/Frame 070261/0765 →
Assignment of Assignor's Interest Feb 19, 2025
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACECUTICALS, INC.
Reel/Frame 070261/0624 →
Assignment of Assignor's Interest Feb 19, 2025
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACECUTICALS, INC.
Reel/Frame 070267/0942 →
Assignment of Assignor's Interest Feb 19, 2025
From: SPIRFIRE PHARMA, INC.
To: MEDERIS DIABETES LLC
Reel/Frame 070262/0648 →
Assignment of Assignor's Interest Feb 19, 2025
From: N, JOHN J.
To: SPITFIRE PHARMA, INC.
Reel/Frame 070262/0605 →
Assignment of Assignor's Interest Feb 19, 2025
From: NESTOR, JOHN J.
To: MEDERIS DIABETES LLC
Reel/Frame 070262/0419 →
Assignment of Assignor's Interest Feb 19, 2025
From: NESTOR, JOHN J.
To: MEDERIS DIABETES LLC
Reel/Frame 070262/0369 →
Assignment of Assignor's Interest Feb 19, 2025
From: EUMEDERIS PHARMACEUTICALS, INC.
To: MEDERIS DIABETES LLC
Reel/Frame 070262/0235 →
Assignment of Assignor's Interest Feb 19, 2025
From: NESTOR, JOHN J.
To: EUMEDERIS PHARMACECUTICALS, INC.
Reel/Frame 070262/0072 →
Security Interest May 14, 2025
From: ALTIMMUNE, INC.; SPITFIRE PHARMA, LLC
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 071108/0692 →